Approved

SCYNEXIS INC
SCYNEXIS INC (SCYX)
WebsitePrice
Market cap
Next catalystExpected Q4 2026SCY-770 — planned ADPKD Phase 2 proof-of-concept study · Trial initiationCompany source ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP1P3FilingApproved
PreINDP1P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Partner / License out
Approved / commercial
Approved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved